XRAY vs. COO: Which Stock Should Value Investors Buy Now?

Dentsply International (XRAY) is presented as a more attractive option for value investors compared to The Cooper Companies (COO), based on Zacks Ranks and Value Style Scores. XRAY holds a Zacks Rank of #2 (Buy) versus COO's #3 (Hold), indicating stronger earnings estimate revisions, and boasts a Value grade of A compared to COO's C, driven by metrics such as a lower forward P/E ratio (8.64 vs 20.09) and PEG ratio (1.17 vs 2.02).

Analysis

Dentsply International (XRAY) presents a more compelling case for value investors compared to The Cooper Companies (COO) within the Medical - Dental Supplies sector, according to an analysis leveraging the Zacks Rank system and Style Scores. XRAY currently holds a Zacks Rank of #2 (Buy), signifying a positive trend in earnings estimate revisions and an improving analyst outlook, whereas COO is rated #3 (Hold). This distinction is further supported by XRAY's superior Value Style Score of 'A', contrasted with COO's 'C'. Key valuation metrics underscore XRAY's attractiveness: its forward Price-to-Earnings (P/E) ratio stands at 8.64, significantly lower than COO's 20.09. Additionally, XRAY's Price/Earnings to Growth (PEG) ratio is 1.17, indicating a more reasonable valuation relative to its expected earnings growth, compared to COO's PEG ratio of 2.02. Furthermore, XRAY's Price-to-Book (P/B) ratio of 1.62 is more favorable than COO's 1.96. Collectively, these factors, particularly the stronger estimate revision activity and more attractive valuation multiples, suggest XRAY is currently the more advantageous option for investors prioritizing value.

Key Decisions for Investors

• Value-focused investors should consider Dentsply International (XRAY) due to its strong Zacks Buy rank, superior 'A' Value Grade, and more attractive valuation metrics including a lower forward P/E, PEG, and P/B ratio compared to The Cooper Companies.
• Investors holding or considering The Cooper Companies (COO) should note its Zacks Hold rank and 'C' Value Grade, alongside higher valuation multiples, which may suggest a less compelling entry point for a pure value strategy at this time.
• Monitor ongoing earnings estimate revisions for both XRAY and COO, as these are key drivers of the Zacks Rank and can signal shifts in fundamental outlook.